Journal of Chest Surgery

  • 제26권6호
  • /
  • Pages.441-451
  • /
  • 1993
  • /
  • 2765-1606(pISSN)
  • /
  • 2765-1614(eISSN)
대한심장혈관흉부외과학회 (The Korean Society for Thoracic and Cardiovascular Surgery)
권호 표지

미세 투석기를 이용한 실험적 급성 허혈 심근에 관한 영구

Investigation of Experimental Acute Ischemic Myocardium with a Microdialysis Appratus

  • 발행 : 1993.06.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Protective effect of superoxide dismutase[SOD] and substrates on acute ischemic and reperfused myocardium was assessed by cardiac microdialysis. 30 Rabbits were divided into 4 groups; normal control group [group I, n=5], ischemic group [group II, n=5], SOD treated group [group III, n=10], and substrates treated group [group IV, n=10]. After a microdialysis apparatus was implanted in rabbit myocardium, coronary artery was occuluded for 5 minutes and reperfusion was performed for 30 minutes. Hemodynamic changes, CK-MB isoenzyme level and adenine ring compound level in effluent dialysates [equilibrated with interstitial fluid], and ultrastructural changes of myocardial cell were analysed. Systolic blood pressure at 10 and 30 minutes after reperfusion was higher in group III and IV than in group II [p<.05]. Also percent recovery of systolic blood pressure in group III [p<.01] and IV [p<.02] was higher than in group II. CK-MB isoenzyme level in effluent dialysates was peaked at 10 minutes after reperfusion, thereafter decreased in group II, III and IV. At 30 minutes after reperfusion, its level was lower in group III and IV than in group II[p<.05]. Adenine ring compound level in effluent dialysates increased till 10 minutes after reperfusion and progressively decreased. At 10 and 30 minutes after reperfusion, its level was lower in group III and IV than in group II without significance. Degree of myocardial damage was estimated by scoring of mitochondrial injury. Group I was within normal range and most severe injury was seen in group II. And the score of mitochondrial injury in group III and IV was lower than in group II. In conclusion, SOD and substrates[KMP solution] had protective effect on stunned myocardium. The microdialysis appratus was a good device for studying stunned myocardium, and cardiac microdialysis might be a unique technique for analysis of regional intramyocardial interstitial fluid.

키워드

참고문헌

  1. The Heart(7th ed.) Atherosclerotic coronary artery disease Hurst,J.W.;Hurst,J.W.;Schlant,R.C.;Rackley,C.E.;Sonenblick,E.H.Wenger,N.K.
  2. Am J Cardiol v.24 Symphosium on the pre-hospital phase of acute myocardial infarction; Early phase of myocardial ischemic injury and infarction Jennings,R.B.
  3. J Clin Invest v.56 Regional myocardial function and electrophysiological alterations after brief cononary artery occlusion in conscious dogs Heyndrickx,G.R.;Millard,R.W.;McRitchie,R.J.(et al.)
  4. Circulation v.66 The stunned myocardium: Prolonged postischemic ventricular dysfunction Braunwald,E.;Kloner,R.A.
  5. Acta Neurochir v.102 Neurometabolic monitoring of the ischemic human brain using microdialysis Hillered,L.;Persson,L.;Ponter,U.;Ungerstedt,U.
  6. Scand J Clin Lab Invest v.49 Microdialysis of subcutaneous adipose tissue in vivo for continuous glucose monitoring in man Bolinder,J.;Hagstrom,E.;Ungerstedt,U.;Arner,P.
  7. Acta Med Okayama v.44 In vivo analysis of extracellular proteins in rat brains with a newly developed intracerebral microdialysis probe Nakamura,M.;Itano,T.;Yamaguchi,F.(et al.)
  8. Am J Physiol v.258 Cardiac microdialysis to estimate interstitial adenosine and coronary blood flow Van Wylen DG;Willis,J.;Sodhi,J.;Weiss,R.J.;Lasley,R.D.:Mentzer,R.M.Jr
  9. Cardiac surgery Cardiac mechanics and energetics: An integrated assessment of chemomechanical performance Krukenkemp,I.B.;Silverman,N.A.;Kron,I.L.;Mavroudis,C.
  10. Myocardial protection in cardiac surgery The pathophysiology of myocardial ischemia Hearse,D.J.;Robert,A.J.
  11. Labo Invest v.40 The wave front phenomenon of myocardial ischemic cell death : Transmural progression of necrosis within the frame-work of ischemic bed size (myocardium at risk) and collateral flow Reimer,K.A.;Jennings,R.B.
  12. 순환기 v.22 실험적 심근경색 model 에서 superoxide dismutase 와 catalase투여가 심근 경색 부위와 심근장애에 미치는 영향 김철호;서정돈;이영우(등)
  13. J Clin invest v.54 The No Reflow phenomenon after temporary coronary occlusion in the dog Kloner,R.A.;Ganote,C.E.;Jennings,R.B.
  14. J Mol Cell Cardiol v.5 Abrupt reoxygenation of the anoxic potassium arrested perfused rat heart: A study of myocardial enzyme release Hearse,D.J.;Humphrey,S.M.;Chain,E.B.
  15. Circulation v.76 Oxypurinol limits myocardial stunning but does not reduce infarct size after reperfusion Puett,D.W.;Forman,M.B.;Cates,C.U.(et al.)
  16. Lab Invest v.47 Biology of disease:Free radicals and tissue injury Freeman,B.A.;Crapo,J.D.
  17. Circ Res v.54 Canine myocardial reperfusion injury. Its reduction by the combined administration of superoxide dismutase and catalase Jolly,S.R.;Kane,W.J.;Bailie,M.B.;Abrams,G.D.;Lucchesi,B.R.
  18. Circulation v.74 Reduction in experimental infarct size by recombinant human superoxide dismutase:insights into the pathogenesis of reperfusion injury Ambrosio,G.;Becker,L.C.;Hutchins,G.M.(et al.)
  19. Circulation v.74 Failure of superoxide dismutase and catalase to alter size of infarction in concious dogs after 3 hours of occlusion followed by reperfusion Gallagher,K.P.;Buda,A.J.;Pace,D.;Green,R.A.;Shlafer,M.
  20. Surgery Reversal of ischemic damage with aminoacid substrate enhancement during reperfusion Lazar,H.L.;Buckberg,G.D.;Manganaro,A.J.(et al.)
  21. 대흉외지 v.22 Doxorubicin에 의한 급성 심근독성과 L-Glutamate의 효과에 관한 실험적 연구 박성달;김송명;정황규
  22. J Clin Invest v.58 Alterations of myocardial aminoacid metabolism in chronic ischemic heart disease Mudge,G.H.;Mills,R.M.;Taegtemyer,H.;Gorlin,R.;Lesch,M.
  23. Circulation v.70 no.SUP. Ⅰ Reduction of postischemic myocardial function by substrate repletion during reperfusion Haas,G.S.;DeBoer,L.W.P.;O'Keefe,D.D. (et al.)
  24. Myocardial protection in cardiac surgery Bretschneider's histidine-buffered cardioplegic solution: concept, application and efficacy Gebhard,M.M.;Breteschneider,H.J.;Gersing,E.;Schnabel,P.A.;Roberts,A.J.
  25. Pharmacological reviews v.43 Nitic oxide: Physiology, pathophysiology and pharmacology Moncada,S.;Palmer,R.M.J.;Higgs,H.A.
  26. Circ Res v.61 Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical Ignarro,L.J.;Byrus,R.E.;Buga,G.M.;Wood,K.S.
  27. Circ Res v.65 Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein Ignarro,L.J.
  28. Endothelium-derived contracting factors Role of endothelium-derived relaxing factors as cardioprotective agent in myocardial ischemia Lefer,A.M.;Tsao,P.S.;Johnson,G.Ⅲ.;Rubanyi,G.M.;Vanhoutte,P.M.
  29. Anesthesiology v.75 EDRF/nitric oxide. The endogenous nitrovasodilator and a new cellular messenger Johns,P.A.